CME Stock Price Today (July 2026) — CME Group Inc. Analysis & Key Metrics 2026-07-17
CME Group Inc. (CME) is trading at $245.05, down 0.50% today (as of July 2026). The stock continues to show pressure below major moving averages, attracting attention from investors looking for Financial Services growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $302.60 (23.5% upside).
- Volatility remains elevated (22.45% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (14.40% YoY) alongside significant competitive pressures.
CME Stock Analysis: Key Metrics & Valuation (July 2026)
Concise, actionable data for investors
CME Group Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $81.25B
P/E Ratio
Forward P/E: 17.65
Revenue Growth
Year over Year
Analyst Target
+23.5% upside potential
Key Investor Questions About CME
What investors need to know before buying
Based on current market data, CME presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 54.61)
- Fundamentals say: Caution warranted (high leverage concerns)
CME's growth trajectory depends on its ability to expand within the Financial Data & Stock Exchanges sector while managing margin pressures.
- Future growth will depend on performance in core Financial Data & Stock Exchanges operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for CME investors include debt exposure and competitive dynamics in the Financial Data & Stock Exchanges industry.
- $3.74B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Financial Data & Stock Exchanges.
52-Week Trading Range
Over the past year, CME stock traded between $218.31 and $329.16—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 22.45% annualized volatility and β=-0.12, the stock exhibits low sensitivity to market moves—making CME suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Q1 Earnings Highlights: CME Group (NASDAQ:CME) Vs The Rest Of The Financial Exchanges & Data Stocks
Let’s dig into the relative performance of CME Group (NASDAQ:CME) and its peers as we unravel the now-completed Q1 financial exchanges & data earnings season.
What's in the Cards for CME Group This Earnings Season?
CME Group's Q2 results are expected to reflect resilient revenue growth from market data and volatility-driven trading despite mixed contract volumes.
The $5.25 billion ETF paying dividends that grew three years straight right now
DIVO has raised its monthly payout three years running and sits on $5.25 billion in assets, but one holding carries a debt load that raises questions about how long the streak can continue.
Nasdaq (NDAQ) Reports Next Week: Wall Street Expects Earnings Growth
Nasdaq (NDAQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NDAQ Stock Rises 1.6% in a Year: A Signal for Investors to Hold Tight?
Nasdaq's expanding non-trading businesses, strategic acquisitions and shareholder returns position it for sustained long-term growth.
“Compute Is the New Oil”: Kalshi Just Launched a Way to Bet on the Future Price of AI Computing Power
Kalshi just launched a way to trade the future price of AI computing power, putting a CFTC-regulated startup on a collision course with the two biggest names in derivatives. The exchange that wins this land grab could own a market its founders say will eventually dwarf oil futures.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group (CME) Launches Treasury Link And A New Agriculture Index
CME Group (NasdaqGS:CME) has launched Treasury Link, a tool that connects U.S. Treasury futures and cash markets for centralized spread trading. The company has also introduced a comprehensive Agriculture Index that tracks the performance of key global farm sectors. Both products represent new platforms within CME Group’s derivatives and benchmarking offerings for institutional and commercial clients. CME Group, known for its global derivatives exchanges, is adding Treasury Link and a broad...
Kalshi Ramps Up Effort to Build Markets for AI Computing Power
(Bloomberg) -- Kalshi Inc. has created a tool that plots the future price of computing power, joining the ranks of exchange and index operators attempting to build markets around the commodity powering artificial intelligence. Most Read from BloombergUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Trump Embraces Australian Retirement System Backed by Larry FinkUS CPI Falls for the First Time Since 2020, Core Gauge FlatDisne
Inflation, Warsh, and War Stoke Treasury Yields, Putting Bond Markets On Edge
U.S. Treasury bond markets continued to ratchet up tension in global finance on Tuesday, with traders watching developments in the Gulf region, a key inflation report, and testimony from new Federal Reserve Chairman Kevin Warsh as yields hit multiyear highs. Benchmark 10-year Treasuries have risen nearly 20 basis points since the start of the month, and were last marked at 4.621%, the highest since reaching 4.66% on May 19. The gains in crude oil prices—and their immediate impact on inflation metrics—is a crucial aspect to the move, as is the hawkish tone heard recently from Fed officials and the lack of definitive guidance under the new leadership of Warsh.
Frequently Asked Questions
Common investor questions about CME Group Inc.
CME Group Inc. (CME) is currently trading at $245.05. The RSI (14-day) is at 54.6, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $302.60 implies 23.5% upside from current levels. Volatility is moderate at 22.4% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for CME Group Inc. (CME): The trailing P/E ratio is 20.89, which is in line with broader market averages. The forward P/E is 17.65, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 3.87, above 2.0, suggesting the stock may be overvalued relative to its expected growth. Price-to-Book is 3.33. Price-to-Sales is 13.13. Valuation should be compared to Financial Data & Stock Exchanges industry peers for context, as different sectors trade at different multiples.
Based on 15 analysts covering CME, the consensus price target is $302.60. This represents a 23.5% upside from the current price of $245.05. The range spans from a low target of $230.00 to a high target of $353.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, CME Group Inc. (CME) pays a dividend with a current yield of approximately 2.12%. The annualized dividend rate is $5.05 per share. The payout ratio is 95.6%, which is relatively high—earnings cover the dividend but there's limited room for increases. The most recent ex-dividend date was 2026-06-09T00:00:00.000Z.
Key risks for CME Group Inc. (CME) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Financial Data & Stock Exchanges sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is CME Group Inc.'s (CME) current debt and financial health profile: Total debt stands at $3.74B. The debt-to-equity ratio is 14.06, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 1.02, indicating adequate short-term liquidity. The quick ratio is 0.02. The company holds $2.52B in cash and equivalents. Free cash flow is positive at $3.03B, providing a cushion for debt servicing and shareholder returns.